SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-19-037056
Filing Date
2019-10-17
Accepted
2019-10-17 09:15:31
Documents
1
Period of Report
2019-10-17
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K sbph-8k_20191017.htm 8-K 34341
  Complete submission text file 0001564590-19-037056.txt   35403
Mailing Address 35 PARKWOOD DRIVE SUITE 210 HOPKINTON MA 01748
Business Address 35 PARKWOOD DRIVE SUITE 210 HOPKINTON MA 01748 508-473-5993 X119
Spring Bank Pharmaceuticals, Inc. (Filer) CIK: 0001566373 (see all company filings)

IRS No.: 522386345 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37718 | Film No.: 191154138
SIC: 2834 Pharmaceutical Preparations